أعرض في EDS

International Guidelines for the Treatment of Huntington's Disease

التفاصيل البيبلوغرافية
العنوان:	International Guidelines for the Treatment of Huntington's Disease
المؤلفون:	Anne-Catherine Bachoud-Lévi, Joaquim Ferreira, Renaud Massart, Katia Youssov, Anne Rosser, Monica Busse, David Craufurd, Ralf Reilmann, Giuseppe De Michele, Daniela Rae, Ferdinando Squitieri, Klaus Seppi, Charles Perrine, Clarisse Scherer-Gagou, Olivier Audrey, Christophe Verny, Jean-Marc Burgunder
المساهمون:	Bachoud-Levi, A. -C., Ferreira, J., Massart, R., Youssov, K., Rosser, A., Busse, M., Craufurd, D., Reilmann, R., De Michele, G., Rae, D., Squitieri, F., Seppi, K., Perrine, C., Scherer-Gagou, C., Audrey, O., Verny, C., Burgunder, J. -M., Gestionnaire, Hal Sorbonne Université, Centre de référence maladie de Huntington, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU)-CHU Trousseau [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), CHU Henri Mondor, Institut de neurosciences translationnelles de Paris (NeurATRIS - IHU-A-ICM), Institut du Cerveau = Paris Brain Institute (ICM), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Cardiff University, University of Manchester [Manchester], Saint Mary's Hospital [London], St Mary's Hospital [London], University of Naples Federico II = Università degli studi di Napoli Federico II, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Innsbruck Medical University = Medizinische Universität Innsbruck (IMU), Service de Génétique Cytogénétique et Embryologie [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM), Biologie Neurovasculaire et Mitochondriale Intégrée (BNMI), Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), University of Bern, Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Trousseau [APHP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), University of Naples Federico II, Innsbruck Medical University [Austria] (IMU), Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université d'Angers (UA)
المصدر:	Frontiers in Neurology, Vol 10 (2019) Bachoud-Lévi, Anne-Catherine; Ferreira, Joaquim; Massart, Renaud; Youssov, Katia; Rosser, Anne; Busse, Monica; Craufurd, David; Reilmann, Ralf; De Michele, Giuseppe; Rae, Daniela; Squitieri, Ferdinando; Seppi, Klaus; Perrine, Charles; Scherer-Gagou, Clarisse; Audrey, Olivier; Verny, Christophe; Burgunder, Jean-Marc (2019). International Guidelines for the Treatment of Huntington's Disease. Frontiers in neurology, 10(710), p. 710. Frontiers Media S.A. 10.3389/fneur.2019.00710 <http://dx.doi.org/10.3389/fneur.2019.00710Test> Frontiers in Neurology Frontiers in Neurology, 2019, 10, pp.710. ⟨10.3389/fneur.2019.00710⟩ Frontiers in Neurology, Frontiers, 2019, 10, pp.710. ⟨10.3389/fneur.2019.00710⟩
بيانات النشر:	Frontiers Media SA, 2019.
سنة النشر:	2019
مصطلحات موضوعية:	medicine.medical_specialty, 610 Medicine & health, Computer-assisted web interviewing, Disease, Guideline, lcsh:RC346-429, Scientific evidence, 03 medical and health sciences, 0302 clinical medicine, Quality of life (healthcare), Policy and Practice Reviews, Huntington's disease, Multidisciplinary approach, medicine, [SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC], guidelines, care, lcsh:Neurology. Diseases of the nervous system, 030304 developmental biology, 0303 health sciences, treatment, business.industry, Cognition, medicine.disease, clinical practice, 3. Good health, Clinical Practice, Neurology, Family medicine, [SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC], Neurology (clinical), business, 030217 neurology & neurosurgery
الوصف:	International audience; The European Huntington's Disease Network (EHDN) commissioned an international task force to provide global evidence-based recommendations for everyday clinical practice for treatment of Huntington's disease (HD). The objectives of such guidelines are to standardize pharmacological, surgical and non-pharmacological treatment regimen and improve care and quality of life of patients. A formalized consensus method, adapted from the French Health Authority recommendations was used. First, national committees (French and English Experts) reviewed all studies published between 1965 and 2015 included dealing with HD symptoms classified in motor, cognitive, psychiatric, and somatic categories. Quality grades were attributed to these studies based on levels of scientific evidence. Provisional recommendations were formulated based on the strength and the accumulation of scientific evidence available. When evidence was not available, recommendations were framed based on professional agreement. A European Steering committee supervised the writing of the final recommendations through a consensus process involving two rounds of online questionnaire completion with international multidisciplinary HD health professionals. Patients' associations were invited to review the guidelines including the HD symptoms. Two hundred and nineteen statements were retained in the final guidelines. We suggest to use this adapted method associating evidence base-medicine and expert consensus to other rare diseases.
وصف الملف:	application/pdf
تدمد:	1664-2295
الوصول الحر:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9676a9fa2e156168f46184787d696f5Test https://doi.org/10.3389/fneur.2019.00710Test
حقوق:	OPEN
رقم الانضمام:	edsair.doi.dedup.....b9676a9fa2e156168f46184787d696f5
قاعدة البيانات:	OpenAIRE

الوصف
تدمد:	16642295